Serodopa Therapeutics
Serodopa Therapeutics is a biopharmaceutical company dedicated to developing new treatments for health conditions, with a particular focus on central nervous system (CNS) disorders. The company leverages prodrug technology and repurposed drugs to address critical health issues such as drug overdose reversal and medical countermeasures. Serodopa is committed to agile and efficient pathways to drug approval, with a mission to provide innovative therapies for underserved populations.
Industries
N/A
Nr. of Employees
small (1-50)
Serodopa Therapeutics
747 SW 2nd Avenue, IMB #41, Gainesville, FL 32601
Products
Prodrug-based therapeutic programs (lead indications: overdose reversal and medical countermeasures)
Lead development programs based on prodrug technology and repurposed drugs targeting overdose reversal and other medical countermeasure indications; patent protection reported.
Prodrug-based therapeutic programs (lead indications: overdose reversal and medical countermeasures)
Lead development programs based on prodrug technology and repurposed drugs targeting overdose reversal and other medical countermeasure indications; patent protection reported.
Expertise Areas
- Prodrug design and development
- Drug repurposing
- CNS drug development
- Overdose-reversal therapeutics
Key Technologies
- Prodrug chemistry
- Drug repurposing methodologies
- Preclinical translational research
- Clinical study execution methods
Key People
Founder & President
Co-Founder
Founder & President
Co-Founder
News & Updates
Serodopa Therapeutics has a patent issued with others pending, focusing on prodrug technology and repurposed drugs for CNS disorders.
Serodopa Therapeutics has a patent issued with others pending, focusing on prodrug technology and repurposed drugs for CNS disorders.